Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
Publication year
2018Source
Bone Marrow Transplantation, 53, 10, (2018), pp. 1255-1262ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Haematology
Journal title
Bone Marrow Transplantation
Volume
vol. 53
Issue
iss. 10
Page start
p. 1255
Page end
p. 1262
Subject
Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Haematology - Radboud University Medical Center; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [243908]
- Faculty of Medical Sciences [92803]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.